AKRO
Price
$54.21
Change
-$0.09 (-0.17%)
Updated
Nov 13, 04:59 PM (EDT)
Capitalization
4.47B
119 days until earnings call
Intraday BUY SELL Signals
NAUT
Price
$1.89
Change
+$0.15 (+8.67%)
Updated
Nov 13, 04:59 PM (EDT)
Capitalization
219.77M
98 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AKRO vs NAUT

Header iconAKRO vs NAUT Comparison
Open Charts AKRO vs NAUTBanner chart's image
Akero Therapeutics
Price$54.21
Change-$0.09 (-0.17%)
Volume$13.75K
Capitalization4.47B
Nautilus Biotechnolgy
Price$1.89
Change+$0.15 (+8.67%)
Volume$1.35K
Capitalization219.77M
AKRO vs NAUT Comparison Chart in %
View a ticker or compare two or three
VS
AKRO vs. NAUT commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AKRO is a StrongBuy and NAUT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (AKRO: $54.30 vs. NAUT: $1.73)
Brand notoriety: AKRO and NAUT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AKRO: 45% vs. NAUT: 52%
Market capitalization -- AKRO: $4.46B vs. NAUT: $238.09M
AKRO [@Biotechnology] is valued at $4.46B. NAUT’s [@Biotechnology] market capitalization is $238.09M. The market cap for tickers in the [@Biotechnology] industry ranges from $110.25B to $0. The average market capitalization across the [@Biotechnology] industry is $2.1B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AKRO’s FA Score shows that 0 FA rating(s) are green whileNAUT’s FA Score has 1 green FA rating(s).

  • AKRO’s FA Score: 0 green, 5 red.
  • NAUT’s FA Score: 1 green, 4 red.
According to our system of comparison, AKRO is a better buy in the long-term than NAUT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AKRO’s TA Score shows that 5 TA indicator(s) are bullish while NAUT’s TA Score has 3 bullish TA indicator(s).

  • AKRO’s TA Score: 5 bullish, 5 bearish.
  • NAUT’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, AKRO is a better buy in the short-term than NAUT.

Price Growth

AKRO (@Biotechnology) experienced а +0.46% price change this week, while NAUT (@Biotechnology) price change was +14.57% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.51%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was +61.90%.

Reported Earning Dates

AKRO is expected to report earnings on Mar 12, 2026.

NAUT is expected to report earnings on Feb 19, 2026.

Industries' Descriptions

@Biotechnology (+1.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AKRO($4.47B) has a higher market cap than NAUT($220M). AKRO YTD gains are higher at: 95.183 vs. NAUT (2.976). NAUT has higher annual earnings (EBITDA): -68.6M vs. AKRO (-279.17M). AKRO has more cash in the bank: 742M vs. NAUT (148M). NAUT has less debt than AKRO: NAUT (28.2M) vs AKRO (37.2M). AKRO (0) and NAUT (0) have equivalent revenues.
AKRONAUTAKRO / NAUT
Capitalization4.47B220M2,032%
EBITDA-279.17M-68.6M407%
Gain YTD95.1832.9763,198%
P/E RatioN/AN/A-
Revenue00-
Total Cash742M148M501%
Total Debt37.2M28.2M132%
FUNDAMENTALS RATINGS
AKRO vs NAUT: Fundamental Ratings
AKRO
NAUT
OUTLOOK RATING
1..100
1724
VALUATION
overvalued / fair valued / undervalued
1..100
34
Fair valued
14
Undervalued
PROFIT vs RISK RATING
1..100
63100
SMR RATING
1..100
9696
PRICE GROWTH RATING
1..100
4235
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NAUT's Valuation (14) in the null industry is in the same range as AKRO (34). This means that NAUT’s stock grew similarly to AKRO’s over the last 12 months.

AKRO's Profit vs Risk Rating (63) in the null industry is somewhat better than the same rating for NAUT (100). This means that AKRO’s stock grew somewhat faster than NAUT’s over the last 12 months.

AKRO's SMR Rating (96) in the null industry is in the same range as NAUT (96). This means that AKRO’s stock grew similarly to NAUT’s over the last 12 months.

NAUT's Price Growth Rating (35) in the null industry is in the same range as AKRO (42). This means that NAUT’s stock grew similarly to AKRO’s over the last 12 months.

NAUT's P/E Growth Rating (100) in the null industry is in the same range as AKRO (100). This means that NAUT’s stock grew similarly to AKRO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AKRONAUT
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 17 days ago
81%
Declines
ODDS (%)
Bearish Trend 10 days ago
82%
Bearish Trend 9 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
AKRO
Daily Signal:
Gain/Loss:
NAUT
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PBQQX27.130.04
+0.15%
PGIM Jennison Blend R6
ASCFX25.550.02
+0.08%
Virtus Small-Cap R6
FMDGX36.06N/A
N/A
Fidelity Mid Cap Growth Index
RRGSX110.98-0.13
-0.12%
T. Rowe Price Growth Stock R
RREYX30.69-0.13
-0.42%
Russell Inv Global Real Estate Secs Y

AKRO and

Correlation & Price change

A.I.dvisor indicates that over the last year, AKRO has been loosely correlated with SLS. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if AKRO jumps, then SLS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AKRO
1D Price
Change %
AKRO100%
+0.09%
SLS - AKRO
38%
Loosely correlated
-1.32%
MDGL - AKRO
37%
Loosely correlated
-2.32%
NAUT - AKRO
35%
Loosely correlated
+4.22%
IDYA - AKRO
35%
Loosely correlated
-0.19%
ENTA - AKRO
35%
Loosely correlated
-0.91%
More

NAUT and

Correlation & Price change

A.I.dvisor indicates that over the last year, NAUT has been loosely correlated with PRLD. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if NAUT jumps, then PRLD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NAUT
1D Price
Change %
NAUT100%
+4.22%
PRLD - NAUT
47%
Loosely correlated
+8.89%
AXON - NAUT
42%
Loosely correlated
-0.47%
ARRY - NAUT
38%
Loosely correlated
-8.69%
IMNM - NAUT
37%
Loosely correlated
-0.51%
KROS - NAUT
36%
Loosely correlated
+3.37%
More